{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-204425","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2024-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.000330+00:00","generated_at":"2026-05-31T08:13:00.834647+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aileron Therapeutics 2024 annual meeting: re-elects directors, ratifies auditor","bullets":["Re-elected Brian Windsor, Ph.D. and Alan A. Musso as Class I directors (7.8M for, ~24k withheld each, 3.4M broker non-votes).","Advisory vote on named executive officer compensation passed: 7.3M for, 109k against, 416k abstain.","Ratified Marcum LLP as independent auditor for FY 2024: 10.8M for, 61k against, 416k abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-204425","json":"https://secwatch.observer/filing/0001193125-24-204425.json","markdown":"https://secwatch.observer/filing/0001193125-24-204425.md","text":"https://secwatch.observer/filing/0001193125-24-204425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/0001193125-24-204425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/d862681d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:13:00.834647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}